Harmony Biosciences (HRMY) has the highest short interest by a US stock in the Pharmaceuticals Industry, with 33.57% of float sold short (6.353M shares).
ASSET | SHARES SHORT | FLOAT | SHORT % OF FLOAT | SHORT RATIO |
---|---|---|---|---|
Harmony Biosciences (HRMY) | 6.3534M | 34.6166M | 33.57% | 15.28 |
Corcept Therapeutics (CORT) | 21.3304M | 84.8252M | 33.11% | 23.77 |
Theravance Biopharma (TBPH) | 7.5203M | 15.8649M | 30.45% | 21.12 |
Innoviva (INVA) | 11.3288M | 51.1363M | 29.49% | 13.53 |
Cassava Sciences (SAVA) | 11.7885M | 40.199M | 29.31% | 16.67 |
Collegium Pharmaceutical (COLL) | 7.118M | 28.7993M | 26.89% | 14.17 |
Phathom Pharmaceuticals (PHAT) | 10.647M | 43.2299M | 26.13% | 12.09 |
Omeros (OMER) | 13.2865M | 51.7103M | 23.98% | 32.44 |
Tarsus Pharmaceuticals (TARS) | 7.8503M | 24.3857M | 21.93% | 10.57 |
Harrow Health (HROW) | 6.1211M | 26.5198M | 20.74% | 10.56 |
Verrica Pharmaceuticals (VRCA) | 4.1848M | 15.0738M | 20.46% | 22.54 |
Aurora Cannabis (ACB) | 5.0765M | 54.3904M | 20.42% | 1.36 |
Axsome Therapeutics (AXSM) | 7.6507M | 34.8774M | 19.44% | 8.86 |
Eyepoint Pharmaceuticals (EYPT) | 6.8454M | 30.7446M | 18.73% | 6.88 |
Ventyx Biosciences (VTYX) | 9.2198M | 41.1972M | 18.21% | 2.75 |
Canopy Growth (CGC) | 11.4981M | 91.0216M | 15.61% | .71 |
Tilray (TLRY) | 116.4524M | 770.4757M | 15.49% | 3.7 |
Scpharmaceuticals (SCPH) | 4.6166M | 18.3228M | 15.24% | 16.78 |
Liquidia Technologies (LQDA) | 7.4308M | 49.8377M | 15.24% | 7.63 |
CorMedix (CRMD) | 8.245M | 54.4312M | 15% | 15.92 |
Revance (RVNC) | 13.5512M | 70.7088M | 14.93% | 5.89 |
Enliven Therapeutics (ELVN) | 4.2328M | 19.54M | 14.76% | 27.23 |
Scilex (SCLX) | 6.5817M | 43.4333M | 14.34% | 4.79 |
Arvinas (ARVN) | 8.6001M | 55.8764M | 14.09% | 10.9 |
cbdMD (YCBD) | 369,364 | 2.495M | 13.95% | .65 |